Oxidative and nitrosative stress in the maintenance of myocardial function

Free Radical Biology and Medicine

Volumn 53, Issue 8, 2012, Pages 1531-1540

  Zhang, Yixuan ^a   Tocchetti, Carlo G ^b   Krieg, Thomas ^c   Moens, An L ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

eNOS uncoupling; Free radicals; Mitochondria; Myocytes; NADPH; Nitrosative stress; Oxidative stress; Superoxide; Xanthine oxidase xanthine oxidoreductase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

APOPTOSIS; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MITOCHONDRION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SARCOPLASMIC RETICULUM; UPREGULATION;

ANIMALS; HUMANS; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84866042834     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.07.010     Document Type: Review

References (140)

1. A. Sabri, H.H. Hughie, and P.A. Lucchesi Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes Antioxid. Redox Signaling 5 2003 731 740
2. R. Ferrari, G. Guardigli, D. Mele, G.F. Percoco, C. Ceconi, and S. Curello Oxidative stress during myocardial ischaemia and heart failure Curr. Pharm. Des 10 2004 1699 1711
3. M.K. Misra, M. Sarwat, P. Bhakuni, R. Tuteja, and N. Tuteja Oxidative stress and ischemic myocardial syndromes. Med. Sci. Monit 15 2009 RA209-219
4. S.C. Dudley Jr., N.E. Hoch, L.A. McCann, C. Honeycutt, L. Diamandopoulos, T. Fukai, D.G. Harrison, S.I. Dikalov, and J. Langberg Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases Circulation 112 2005 1266 1273
5. H.C. Williams, and K.K. Griendling NADPH oxidase inhibitors: new antihypertensive agents? J. Cardiovasc. Pharmacol. 50 2007 9 16
6. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol. Rev. 87 2007 245 313
7. S. Umar, and A. van der Laarse Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart Mol. Cell. Biochem. 333 2010 191 201
8. Q. Zeng, Q. Zhou, F. Yao, S.T. O'Rourke, and C. Sun Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide J. Pharmacol. Exp. Ther. 326 2008 732 738
9. R.P. Brandes, N. Weissmann, and K. Schroder NADPH oxidases in cardiovascular disease Free Radic. Biol. Med. 49 2010 687 706
10. D.I. Brown, and K.K. Griendling Nox proteins in signal transduction Free Radic. Biol. Med. 47 2009 1239 1253
11. C. Nediani, L. Raimondi, E. Borchi, and E. Cerbai Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications Antioxid. Redox Signaling 14 2011 289 331
12. H. Sumimoto Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species FEBS J 275 2008 3249 3277
13. A.N. Lyle, N.N. Deshpande, Y. Taniyama, B. Seidel-Rogol, L. Pounkova, P. Du, C. Papaharalambus, B. Lassegue, and K.K. Griendling Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells Circ. Res. 105 2009 249 259
14. T. Ago, J. Kuroda, J. Pain, C. Fu, H. Li, and J. Sadoshima Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes Circ. Res. 106 2010 1253 1264
15. Y. Maejima, J. Kuroda, S. Matsushima, T. Ago, and J. Sadoshima Regulation of myocardial growth and death by NADPH oxidase J. Mol. Cell. Cardiol. 50 2011 408 416
16. S.I. Dikalov, A.E. Dikalova, A.T. Bikineyeva, H.H. Schmidt, D.G. Harrison, and K.K. Griendling Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production Free Radic. Biol. Med. 45 2008 1340 1351
17. L. Serrander, L. Cartier, K. Bedard, B. Banfi, B. Lardy, O. Plastre, A. Sienkiewicz, L. Forro, W. Schlegel, and K.H. Krause NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation Biochem. J. 406 2007 105 114
18. I. Takac, K. Schroder, L. Zhang, B. Lardy, N. Anilkumar, J.D. Lambeth, A.M. Shah, F. Morel, and R.P. Brandes The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4 J. Biol. Chem. 286 2011 13304 13313
19. Y.H. Looi, D.J. Grieve, A. Siva, S.J. Walker, N. Anilkumar, A.C. Cave, M. Marber, M.J. Monaghan, and A.M. Shah Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction Hypertension 51 2008 319 325
20. J.K. Bendall, A.C. Cave, C. Heymes, N. Gall, and A.M. Shah Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice Circulation 105 2002 293 296
21. J.A. Byrne, D.J. Grieve, J.K. Bendall, J.M. Li, C. Gove, J.D. Lambeth, A.C. Cave, and A.M. Shah Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy Circ. Res. 93 2003 802 805
22. S.D. Hingtgen, X. Tian, J. Yang, S.M. Dunlay, A.S. Peek, Y. Wu, R.V. Sharma, J.F. Engelhardt, and R.L. Davisson Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy Physiol. Genomics 26 2006 180 191
23. J. Kuroda, T. Ago, S. Matsushima, P. Zhai, M.D. Schneider, and J. Sadoshima NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart Proc. Natl. Acad. Sci. USA 107 2010 15565 15570
24. M. Zhang, A.C. Brewer, K. Schroder, C.X. Santos, D.J. Grieve, M. Wang, N. Anilkumar, B. Yu, X. Dong, S.J. Walker, R.P. Brandes, and A.M. Shah NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis Proc. Natl. Acad. Sci. USA 107 2010 18121 18126
25. A.M. Kubin, R. Skoumal, P. Tavi, A. Konyi, A. Perjes, H. Leskinen, H. Ruskoaho, and I. Szokodi Role of reactive oxygen species in the regulation of cardiac contractility J. Mol. Cell. Cardiol. 50 2011 884 893
26. A. Cave Selective targeting of NADPH oxidase for cardiovascular protection Curr. Opin. Pharmacol. 9 2009 208 213
27. E.E. Kelley, N.K. Khoo, N.J. Hundley, U.Z. Malik, B.A. Freeman, and M.M. Tarpey Hydrogen peroxide is the major oxidant product of xanthine oxidase Free Radic. Biol. Med. 48 2010 493 498
28. J. George, and A.D. Struthers The role of urate and xanthine oxidase inhibitors in cardiovascular disease Cardiovasc. Ther. 26 2008 59 64
29. R. Kumar, Darpan, S. Sharma, and R. Singh Xanthine oxidase inhibitors: a patent survey Expert Opin. Ther. Pat. 21 2011 1071 1108
30. W.F. Saavedra, N. Paolocci St, M.E. John, M.W. Skaf, G.C. Stewart, J.S. Xie, R.W. Harrison, J. Zeichner, D. Mudrick, E. Marban, D.A. Kass, and J.M. Hare Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart Circ. Res. 90 2002 297 304
31. K.M. Minhas, R.M. Saraiva, K.H. Schuleri, S. Lehrke, M. Zheng, A.P. Saliaris, C.E. Berry, L.A. Barouch, K.M. Vandegaer, D. Li, and J.M. Hare Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy Circ. Res. 98 2006 271 279
32. C. Doerries, K. Grote, D. Hilfiker-Kleiner, M. Luchtefeld, A. Schaefer, S.M. Holland, S. Sorrentino, C. Manes, B. Schieffer, H. Drexler, and U. Landmesser Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction Circ. Res. 100 2007 894 903
33. B.E. Lee, A.H. Toledo, R. Anaya-Prado, R.R. Roach, and L.H. Toledo-Pereyra Allopurinol, xanthine oxidase, and cardiac ischemia J. Invest. Med. 57 2009 902 909
34. X. Xu, X. Hu, Z. Lu, P. Zhang, L. Zhao, J.L. Wessale, R.J. Bache, and Y. Chen Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice J. Card. Failure 14 2008 746 753
35. L.G. Gao, X.P. Yao, L. Zhang, D. Wen, F. Luo, X.L. Zhou, and R.T. Hui Febuxostat, a nonpurine selective inhibitor of xanthine oxidase: a promising medical therapy for chronic heart failure? Chin. Med. J. 123 2010 2471 2474
36. G. Nasr, and C. Maurice Allopurinol and global left myocardial function in heart failure patients J. Cardiovasc. Dis. Res 1 2010 191 195
37. J.M. Hare, B. Mangal, J. Brown, C. Fisher Jr, R. Freudenberger, W.S. Colucci, D.L. Mann, P. Liu, M.M. Givertz, and R.P. Schwarz Impact of oxypurinol in patients with symptomatic heart failure: results of the OPT-CHF study J. Am. Coll. Cardiol. 51 2008 2301 2309
38. L. Zhao, B.M. Roche, J.L. Wessale, A. Kijtawornrat, J.L. Lolly, D. Shemanski, and R.L. Hamlin Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment Life Sci. 82 2008 495 502
39. K. Hayashi, H. Kimata, K. Obata, A. Matsushita, A. Fukata, K. Hashimoto, A. Noda, M. Iwase, Y. Koike, M. Yokota, and K. Nagata Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters J. Card. Failure 14 2008 238 244
40. L.B. Stull, M.K. Leppo, L. Szweda, W.D. Gao, and E. Marban Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy Circ. Res. 95 2004 1005 1011
41. B. Halliwell, and J. Gutteridge Free Radicals in Biology and Medicine 2007 Oxford Univ. Press London
42. C. Nathan Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100 1997 2417 2423
43. M.G. Vila-Petroff, A. Younes, J. Egan, E.G. Lakatta, and S.J. Sollott Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes Circ. Res. 84 1999 1020 1031
44. D.L. Campbell, J.S. Stamler, and H.C. Strauss Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual mechanism regulation by nitric oxide and S-nitrosothiols J. Gen. Physiol. 108 1996 277 293
45. L.A. Barouch, R.W. Harrison, M.W. Skaf, G.O. Rosas, T.P. Cappola, Z.A. Kobeissi, I.A. Hobai, C.A. Lemmon, A.L. Burnett, B. O'Rourke, E.R. Rodriguez, P.L. Huang, J.A. Lima, D.E. Berkowitz, and J.M. Hare Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms Nature 416 2002 337 339
46. E. Takimoto, H.C. Champion, D. Belardi, J. Moslehi, M. Mongillo, E. Mergia, D.C. Montrose, T. Isoda, K. Aufiero, M. Zaccolo, W.R. Dostmann, C.J. Smith, and D.A. Kass cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism Circ. Res. 96 2005 100 109
47. M. Mongillo, C.G. Tocchetti, A. Terrin, V. Lissandron, Y.F. Cheung, W.R. Dostmann, T. Pozzan, D.A. Kass, N. Paolocci, M.D. Houslay, and M. Zaccolo Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway Circ. Res. 98 2006 226 234
48. E. Takimoto, and D.A. Kass Role of oxidative stress in cardiac hypertrophy and remodeling Hypertension 49 2007 241 248
49. M.T. Ziolo, C.H. Harshbarger, K.E. Roycroft, J.M. Smith, F.D. Romano, K.L. Sondgeroth, and G.M. Wahler Myocytes isolated from rejecting transplanted rat hearts exhibit a nitric oxide-mediated reduction in the calcium current J. Mol. Cell. Cardiol. 33 2001 1691 1699
50. M.T. Ziolo, H. Katoh, and D.M. Bers Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes Circulation 104 2001 2961 2966
51. N. Keira, T. Tatsumi, S. Matoba, J. Shiraishi, S. Yamanaka, K. Akashi, M. Kobara, J. Asayama, S. Fushiki, H. Fliss, and M. Nakagawa Lethal effect of cytokine-induced nitric oxide and peroxynitrite on cultured rat cardiac myocytes J. Mol. Cell. Cardiol. 34 2002 583 596
52. H. Drexler Nitric oxide synthases in the failing human heart: a doubled-edged sword? Circulation 99 1999 2972 2975
53. 2 transients Circulation 109 2004 1886 1891
54. R. Feil, S.M. Lohmann, H. de Jonge, U. Walter, and F. Hofmann Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice Circ. Res. 93 2003 907 916
55. J.M. Hare Nitroso-redox balance in the cardiovascular system N. Engl. J. Med. 351 2004 2112 2114
56. N. Paolocci, U.E. Ekelund, T. Isoda, M. Ozaki, K. Vandegaer, D. Georgakopoulos, R.W. Harrison, D.A. Kass, and J.M. Hare cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation Am. J. Physiol. Heart Circ. Physiol 279 2000 H1982 1988
57. F.J. Giordano Oxygen, oxidative stress, hypoxia, and heart failure J. Clin. Invest. 115 2005 500 508
58. T. Katori, S. Donzelli, C.G. Tocchetti, K.M. Miranda, G. Cormaci, D.D. Thomas, E.A. Ketner, M.J. Lee, D. Mancardi, D.A. Wink, D.A. Kass, and N. Paolocci Peroxynitrite and myocardial contractility: in vivo versus in vitro effects Free Radic. Biol. Med. 41 2006 1606 1618
59. 2-ATPase in human heart failure Circulation 111 2005 988 995
60. E. Takimoto, D. Belardi, C.G. Tocchetti, S. Vahebi, G. Cormaci, E.A. Ketner, A.L. Moens, H.C. Champion, and D.A. Kass Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5 Circulation 115 2007 2159 2167
61. P.M. Hassoun, F.S. Yu, J.J. Zulueta, A.C. White, and J.J. Lanzillo Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase Am. J. Physiol. 268 1995 L809 817
62. C.G. Cote, F.S. Yu, J.J. Zulueta, R.J. Vosatka, and P.M. Hassoun Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide Am. J. Physiol. 271 1996 L869 874
63. M. Shinyashiki, C.J. Pan, B.E. Lopez, and J.M. Fukuto Inhibition of the yeast metal reductase heme protein fre1 by nitric oxide (NO): a model for inhibition of NADPH oxidase by NO Free Radic. Biol. Med. 37 2004 713 723
64. R.M. Clancy, J. Leszczynska-Piziak, and S.B. Abramson Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase J. Clin. Invest. 90 1992 1116 1121
65. L.M. Bevers, B. Braam, J.A. Post, A.J. van Zonneveld, T.J. Rabelink, H.A. Koomans, M.C. Verhaar, and J.A. Joles Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase Hypertension 47 2006 87 94
66. J. Vasquez-Vivar, P. Martasek, J. Whitsett, J. Joseph, and B. Kalyanaraman The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study Biochem. J 362 2002 733 739
67. E. Takimoto, H.C. Champion, M. Li, S. Ren, E.R. Rodriguez, B. Tavazzi, G. Lazzarino, N. Paolocci, K.L. Gabrielson, Y. Wang, and D.A. Kass Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load J. Clin. Invest. 115 2005 1221 1231
68. A.L. Moens, E. Takimoto, C.G. Tocchetti, K. Chakir, D. Bedja, G. Cormaci, E.A. Ketner, M. Majmudar, K. Gabrielson, M.K. Halushka, J.B. Mitchell, S. Biswal, K.M. Channon, M.S. Wolin, N.J. Alp, N. Paolocci, H.C. Champion, and D.A. Kass Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy Circulation 117 2008 2626 2636
69. H. Cai, Z. Li, A. Goette, F. Mera, C. Honeycutt, K. Feterik, J.N. Wilcox, S.C. Dudley Jr, D.G. Harrison, and J.J. Langberg Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2002 2854 2858
70. Y.M. Kim, T.J. Guzik, Y.H. Zhang, M.H. Zhang, H. Kattach, C. Ratnatunga, R. Pillai, K.M. Channon, and B. Casadei A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation Circ. Res. 97 2005 629 636
71. Y. Nishijima, A. Sridhar, I. Bonilla, M. Velayutham, M. Khan, R. Terentyeva, C. Li, P. Kuppusamy, T.S. Elton, D. Terentyev, S. Gyorke, J.L. Zweier, A.J. Cardounel, and C.A. Carnes Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology Cardiovasc. Res. 91 2011 71 79
72. H.J. Crijns, U. Schotten, and A.L. Moens Is NOS uncoupling the missing link between atrial fibrillation and chronic non-ischaemic cardiomyopathy? Cardiovasc. Res 91 556 2011 557 558 author reply
73. T.E. Peterson, L.V. d'Uscio, S. Cao, X.L. Wang, and Z.S. Katusic Guanosine triphosphate cyclohydrolase I expression and enzymatic activity are present in caveolae of endothelial cells Hypertension 53 2009 189 195
74. G. Lim, L. Venetucci, D.A. Eisner, and B. Casadei Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling Cardiovasc. Res. 77 2008 256 264
75. C.G. Tocchetti, B.A. Stanley, C.I. Murray, V. Sivakumaran, S. Donzelli, D. Mancardi, P. Pagliaro, W.D. Gao, J. van Eyk, D.A. Kass, D.A. Wink, and N. Paolocci Playing with cardiac redox switches: the HNO way to modulate cardiac function Antioxid. Redox Signaling 14 2011 1687 1698
76. 2 release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors Cell Calcium 37 2005 87 96
77. 2 cycling Circ. Res. 100 2007 96 104
78. T. Dai, Y. Tian, C.G. Tocchetti, T. Katori, A.M. Murphy, D.A. Kass, N. Paolocci, and W.D. Gao Nitroxyl increases force development in rat cardiac muscle J. Physiol. 580 2007 951 960
79. 2-cycling. Elite Front. Biosci 2 2010 614 626
80. J.P. Froehlich, J.E. Mahaney, G. Keceli, C.M. Pavlos, R. Goldstein, A.J. Redwood, C. Sumbilla, D.I. Lee, C.G. Tocchetti, D.A. Kass, N. Paolocci, and J.P. Toscano Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl Biochemistry 47 2008 13150 13152
81. R. Bolli, Q.H. Li, X.L. Tang, Y. Guo, Y.T. Xuan, G. Rokosh, and B. Dawn The late phase of preconditioning and its natural clinical application - gene therapy Heart Failure Rev 12 2007 189 199
82. M.B. West, G. Rokosh, D. Obal, M. Velayutham, Y.T. Xuan, B.G. Hill, R.J. Keith, J. Schrader, Y. Guo, D.J. Conklin, S.D. Prabhu, J.L. Zweier, R. Bolli, and A. Bhatnagar Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition Circulation 118 2008 1970 1978
83. N. Kobayashi, S. Horinaka, S. Mita, K. Yoshida, T. Honda, T. Kobayashi, K. Hara, T. Nishikimi, and H. Matsuoka Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats J. Hypertension 20 2002 2475 2485
84. M.J. Mihm, C.M. Coyle, B.L. Schanbacher, D.M. Weinstein, and J.A. Bauer Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure Cardiovasc. Res. 49 2001 798 807
85. H. Drexler Endothelium as a therapeutic target in heart failure Circulation 98 1998 2652 2655
86. I.N. Mungrue, D.J. Stewart, and M. Husain The Janus faces of iNOS. Circ. Res. 93 2003 e74
87. J. Goretski, and T.C. Hollocher Trapping of nitric oxide produced during denitrification by extracellular hemoglobin J. Biol. Chem. 263 1988 2316 2323
88. H. Otani The role of nitric oxide in myocardial repair and remodeling Antioxid. Redox Signaling 11 2009 1913 1928
89. M.A. Aon, S. Cortassa, B. O'Rourke, and ROS Redox-optimized balance: a unifying hypothesis Biochim. Biophys. Acta 1797 2010 865 877
90. F. Di Lisa, M. Canton, R. Menabo, G. Dodoni, and P. Bernardi Mitochondria and reperfusion injury: the role of permeability transition Basic Res. Cardiol. 98 2003 235 241
91. A.P. Halestrap A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection Biochem. Soc. Trans. 38 2010 841 860
92. T.L. Vanden Hoek, C. Li, Z. Shao, P.T. Schumacker, and L.B. Becker Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion J. Mol. Cell. Cardiol. 29 1997 2571 2583
93. G. Loor, J. Kondapalli, H. Iwase, N.S. Chandel, G.B. Waypa, R.D. Guzy, T.L. Vanden Hoek, and P.T. Schumacker Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion Biochim. Biophys. Acta 1813 2011 1382 1394
94. 2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix Cell Metab. 13 2011 340 350
95. Y.M. Tsutsumi, T. Yokoyama, Y. Horikawa, D.M. Roth, and H.H. Patel Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization Life Sci. 81 2007 1223 1227
96. D.J. Hausenloy, A.M. Wynne, and D.M. Yellon Ischemic preconditioning targets the reperfusion phase Basic Res. Cardiol. 102 2007 445 452
97. T. Dost, M.V. Cohen, and J.M. Downey Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning Basic Res. Cardiol. 103 2008 378 384
98. V.J. Adlam, J.C. Harrison, C.M. Porteous, A.M. James, R.A. Smith, M.P. Murphy, and I.A. Sammut Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury FASEB J 19 2005 1088 1095
99. F. Di Lisa, and P. Bernardi Mitochondrial function and myocardial aging: A critical analysis of the role of permeability transition Cardiovasc. Res 66 2005 222 232
100. N. Kaludercic, E. Takimoto, T. Nagayama, N. Feng, E.W. Lai, D. Bedja, K. Chen, K.L. Gabrielson, R.D. Blakely, J.C. Shih, K. Pacak, D.A. Kass, F. Di Lisa, and N. Paolocci Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload Circ. Res. 106 2010 193 202
101. L. Raimondi, G. Banchelli, L. Sgromo, R. Pirisino, M. Ner, A. Parini, and C. Cambon Hydrogen peroxide generation by monoamine oxidases in rat white adipocytes: role on cAMP production Eur. J. Pharmacol. 395 2000 177 182
102. T. Ago, and J. Sadoshima Thioredoxin and ventricular remodeling J. Mol. Cell. Cardiol. 41 2006 762 773
103. 2 emission from isolated heart mitochondria J. Biol. Chem. 286 2011 33669 33677
104. 2 in rat cardiac myocytes Am. J. Physiol. Cell Physiol 281 2001 C1542 1550
105. + exchange in neonatal rat cardiac myocytes Circ. Res. 82 1998 1053 1062
106. 2 regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways J. Mol. Cell. Cardiol. 35 2003 615 621
107. L. Xiao, D.R. Pimental, J.K. Amin, K. Singh, D.B. Sawyer, and W.S. Colucci MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes J. Mol. Cell. Cardiol. 33 2001 779 787
108. K. Tanaka, M. Honda, and T. Takabatake Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte J. Am. Coll. Cardiol. 37 2001 676 685
109. K. Nakamura, K. Fushimi, H. Kouchi, K. Mihara, M. Miyazaki, T. Ohe, and M. Namba Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II Circulation 98 1998 794 799
110. S. Delbosc, J.P. Cristol, B. Descomps, A. Mimran, and B. Jover Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress Hypertension 40 2002 142 147
111. J.K. Amin, L. Xiao, D.R. Pimental, P.J. Pagano, K. Singh, D.B. Sawyer, and W.S. Colucci Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes J. Mol. Cell. Cardiol. 33 2001 131 139
112. G.M. Kuster, D.R. Pimentel, T. Adachi, Y. Ido, D.A. Brenner, R.A. Cohen, R. Liao, D.A. Siwik, and W.S. Colucci Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras Circulation 111 2005 1192 1198
113. V.C. Tu, J.J. Bahl, and Q.M. Chen Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase J. Pharmacol. Exp. Ther. 300 2002 1101 1110
114. S. Hirotani, K. Otsu, K. Nishida, Y. Higuchi, T. Morita, H. Nakayama, O. Yamaguchi, T. Mano, Y. Matsumura, H. Ueno, M. Tada, and M. Hori Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy Circulation 105 2002 509 515
115. T.H. Cheng, P.Y. Cheng, N.L. Shih, I.B. Chen, D.L. Wang, and J.J. Chen Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts J. Am. Coll. Cardiol. 42 2003 1845 1854
116. D.A. Siwik, P.J. Pagano, and W.S. Colucci Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts Am. J. Physiol. Cell Physiol 280 2001 C53 60
117. F.G. Spinale Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases Circ. Res 91 2002 1082 1084
118. D. Sorescu, and K.K. Griendling Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure Congest. Heart Failure 8 2002 132 140
119. D.A. Siwik, and W.S. Colucci Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium Heart Failure Rev 9 2004 43 51
120. D. Cesselli, I. Jakoniuk, L. Barlucchi, A.P. Beltrami, T.H. Hintze, B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy Circ. Res. 89 2001 279 286
121. O. Yamaguchi, Y. Higuchi, S. Hirotani, K. Kashiwase, H. Nakayama, S. Hikoso, T. Takeda, T. Watanabe, M. Asahi, M. Taniike, Y. Matsumura, I. Tsujimoto, K. Hongo, Y. Kusakari, S. Kurihara, K. Nishida, H. Ichijo, M. Hori, and K. Otsu Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling Proc. Natl. Acad. Sci. USA 100 2003 15883 15888
122. 2 channel Mol. Pharmacol 53 1998 497 503
123. A.V. Zima, and L.A. Blatter Redox regulation of cardiac calcium channels and transporters Cardiovasc. Res. 71 2006 310 321
124. 2 channel alpha1C subunits by redox agents and hypoxia J. Physiol. 514 1999 629 637
125. 2-ATPase function by direct attack on the ATP binding site Circ. Res. 80 1997 76 81
126. T. Adachi, R.M. Weisbrod, D.R. Pimentel, J. Ying, V.S. Sharov, C. Schoneich, and R.A. Cohen S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide Nat. Med 10 2004 1200 1207
127. H. Nakagami, M. Takemoto, and J.K. Liao NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy J. Mol. Cell. Cardiol. 35 2003 851 859
128. F. Fiordaliso, I. Cuccovillo, R. Bianchi, A. Bai, M. Doni, M. Salio, N. De Angelis, P. Ghezzi, R. Latini, and S. Masson Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes Life Sci. 79 2006 121 129
129. A. Fortuno, J. Bidegain, P.A. Robador, J. Hermida, J. Lopez-Sagaseta, O. Beloqui, J. Diez, and G. Zalba Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension Hypertension 54 2009 744 750
130. B. Huisamen, S.J. Perel, S.O. Friedrich, R. Salie, H. Strijdom, and A. Lochner ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance Mol. Cell. Biochem 349 2011 21 31
131. K. Brixius, W. Bloch, C. Ziskoven, B. Bolck, A. Napp, C. Pott, D. Steinritz, M. Jiminez, K. Addicks, J.P. Giacobino, and R.H. Schwinger Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium Can. J. Physiol. Pharmacol. 84 2006 1051 1060
132. A.L. Moens, J.S. Leyton-Mange, X. Niu, R. Yang, O. Cingolani, E.K. Arkenbout, H.C. Champion, D. Bedja, K.L. Gabrielson, J. Chen, Y. Xia, A.B. Hale, K.M. Channon, M.K. Halushka, N. Barker, F.L. Wuyts, P.M. Kaminski, M.S. Wolin, D.A. Kass, and L.A. Barouch Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor J. Mol. Cell. Cardiol. 47 2009 576 585
133. A. Cordle, J. Koenigsknecht-Talboo, B. Wilkinson, A. Limpert, and G. Landreth Mechanisms of statin-mediated inhibition of small G-protein function J. Biol. Chem. 280 2005 34202 34209
134. K. Wingler, J.J. Hermans, P. Schiffers, A. Moens, M. Paul, and H.H. Schmidt NOX1, 2, 4, 5: counting out oxidative stress Br. J. Pharmacol. 164 2011 866 883
135. V. Jaquet, L. Scapozza, R.A. Clark, and K.H. Krause Lambeth, J. D. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets Antioxid. Redox Signal. 11 2009 2535 2552
136. - and systolic blood pressure in mice Circ. Res. 89 2001 408 414
137. E. Takimoto, H.C. Champion, M. Li, D. Belardi, S. Ren, E.R. Rodriguez, D. Bedja, K.L. Gabrielson, Y. Wang, and D.A. Kass Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy Nat. Med 11 2005 214 222
138. N. Paolocci, W.F. Saavedra, K.M. Miranda, C. Martignani, T. Isoda, J.M. Hare, M.G. Espey, J.M. Fukuto, M. Feelisch, D.A. Wink, and D.A. Kass Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling Proc. Natl. Acad. Sci. USA 98 2001 10463 10468
139. - in failing hearts: independence from beta-adrenergic signaling Proc. Natl. Acad. Sci. USA 100 2003 5537 5542
140. G. Hasenfuss, and J.R. Teerlink Cardiac inotropes: current agents and future directions Eur. Heart J. 32 2011 1838 1845